FIRMQUARRY / COMPANY INTELLIGENCE
['JASIKA d.o.o.', 'PHOENIX Farmacija d.o.o.', 'MEDICAL INTERTRADE d.o.o.', 'B. Braun Adria d.o.o.', 'OKTAL PHARMA d.o.o.', 'ROCHE d.o.o.', 'MEDIKA, d.d.']
Not reported · Verified headquarters unavailable
General information
- Legal name
- ['JASIKA d.o.o.', 'PHOENIX Farmacija d.o.o.', 'MEDICAL INTERTRADE d.o.o.', 'B. Braun Adria d.o.o.', 'OKTAL PHARMA d.o.o.', 'ROCHE d.o.o.', 'MEDIKA, d.d.']
- First / latest observed
- Oct 23, 2026 — Oct 23, 2026
SUPPORTED COMPANY SIGNALS
Company change signals
Only supported categories appear in the default dossier. Opening from a specific screener keeps that category in focus. Evidence scores are not probabilities.
Company and locations stay distinct
Supported locations & events
Operating locations require independent verification. Recipient addresses and contract work sites are not automatically company facilities.
Expansion
- New federal award+3.7
Signal coverage and missing inputs
Multi-source indication scores
Descriptive expansion indication from 1 deduplicated signals across 1 independent source families. Points apply published evidence caps, reliability, strength, confidence, and 180-day time decay; this is not a probability.
As of Oct 28, 2026 · company-change-indication-v2 · medium evidenceIndividual source-backed indicators
No conservatively linked early indicators are available.
One source-backed chronology
Timeline
Business change, facilities, workforce, corporate events, and government activity appear chronologically.
- GovernmentAward announced
Ostali lijekovi (koji nisu uključeni u kategorije pod rednim brojem 1. i 17.) – VII za zdravstvene ustanove u Republici Hrvatskoj
Disclosed procurement context
Government Business
Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.
Global government business
Markets and currencies remain separate; incompatible currencies are never summed.
| Market | Disclosed value | Currency | Latest activity | Processes |
|---|---|---|---|---|
| HRV | €1.6M | EUR | Nov 3, 2026 | 1 |
Evidence and identifiers
Sources & Coverage
Technical identifiers live here, with retained official links and visible coverage limitations.
Source identifiers
- OCDS_PARTYeu_ted:cfe63e40-c60b-4bc4-8cba-782ae3d13694:ec3e27e8-6103-431c-9339-547870f81623:0 · source ↗